4Zhang HW, Sun W, Yang J, et al. Diagnosis and treatment of pituitary microadenoma: report of 80 cases[J]. Neurol Res, 2008,30 (6) : 587-593.
5Boianov M,Vezenkova L,Khristov V. Suppression of hy- perprolactinemia in pituitary mieroadenoma with cabergo- line (Dostinex)[J]. Akush Ginekol (Sofiia) ,2005,44(5) 34-38.
6Anagnostis P, Adamidou F,Polyzos SA, et al. Long term follow-up of patients with prolaetinomas and outcome of dopamine agonist withdrawal: a single outcome of dopa- mine agonist withdrawal: a single center experience[J]. Pituitary, 2012,15 (1) : 25-29.
7Sharma JB, Roy KK, Mohanraj P. et al. Pregnancy out- come in pituitary tumors[J]. Arch Gynecol Obstet,2009, 280(3) ;401-414.
8Veldzquez-Chdvez FJ, Tapia-Gonzdlez Mde L, Gonzdlez- Bdrcena D. Usefulness of cabergoline in patients with prolactinemia and resistant or intolerant to bromocriptine [J]. Cir Cir,2009,77(3) : 173-177.
9Anagnostis P, Adamidou F, Polyzos SA. et. Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal:a single center experience [J]. Pituitary,2012,15(1) : 25-29.
10Velija-Asmi Z. The efficacy of octreotide LAR in aerome-galie patients as primary or Secondary therapy[J]. Ther Adv Endoerinol Metab,2012,3(1) ,3-9.
